新城疫病毒样颗粒研究进展

doi:10.16431/j.cnki.1671-7236.2022.04.033

Abstract

Abstract: Newcastle disease (ND) is an acute,highly contagious avian infectious disease caused by Newcastle disease virus (NDV),with respiratory,digestive and nervous system symptoms as the main characteristics,the mortality rate in susceptible poultry is as high as 100%,which has brought serious economic losses to poultry breeding and trade in China and the world.Virus-like particles (VLPs) are virus-like protein particles that are formed by in vitro expression or spontaneous assembly of viral proteins during the infection process,which do not contain viral genome,cannot replicate,and have no infectious ability.The suitable size and unique surface structure of VLPs can be effectively recognized by natural immune cells and molecules,and induce good innate and adaptive immune responses.In addition,VLPs do not contain viral infectious nucleic acids and are highly safe.In recent years,they have become a research hotspot in the field of vaccines.Dendritic cells (DCs),as full-time antigen-presenting cells,have a unique function between innate immunity and adaptive immunity,and are currently the full-time immune cells with the strongest antigen-presenting ability.Migration of mature DCs (mDCs) to secondary lymphoid tissues can stimulate the activation and proliferation of primary T cells,and is considered to be the initiator of specific immune responses.Immature DCs (imDCs) cultured in vitro can also help enhance the ability of antigen presentation.NDV-VLPs mainly use NDV-M protein as the backbone to assemble HN,F and NP proteins,which can show similar appearance and immunogenicity to live NDV particles.It can be seen that vaccines made by NDV-VLPs also have many advantages,such as safety,stability,stimulating humoral and cellular immune responses,expressing other antigens as carriers,and being designed to distinguish natural infections from immunization.Therefore,the article mainly discusses the related content of NDV-VLPs in order to provide reference for follow-up research.

Key words: Newcastle disease virus (NDV); virus-like particles (VLPs); dendritic cells; vaccine

CLC Number:

S852.65^＋7

CHI Shanshan, JIA Weijuan, HE Yunjiang, MENG Qinglei, CHEN Yunjiao, WANG Xueli. Research Progress on Newcastle Disease Virus-like Particles[J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(4): 1507-1515.

References

[1] WU X,ZHAI X,LAI Y,et al.Construction and immunogenicity of novel chimeric virus-like particles bearing antigens of infectious Bronchitis virus and Newcastle disease virus[J].Viruses,2019,11(3):254.
[2] 马博文.新城疫病毒样颗粒疫苗研究进展[J].畜牧兽医杂志,2017,36(2):19-20. MA B W.Research progress of Newcastle disease virus-like particles vaccine[J].Journal of Animal Science and Veterinary Medicine,2017,36(2):19-20.(in Chinese)
[3] BASHIR B M,KHATIJAH Y,AINI I,et al.Diagnostic and vaccination approaches for Newcastle disease virus in poultry:The current and emerging perspectives[J].Biomed Research International,2018,2018:7278459.
[4] CHEN Y,ZHU S,HU J,et al.gga-miR-1603 and gga-miR-1794 directly target viral L gene and function as a broad-spectrum antiviral factor against NDV replication[J].Virulence,2021,12(1):45-56.
[5] 王静静,于晓慧,罗瑶瑶,等.2014－2018年我国5株基因Ⅶ型新城疫病毒的基因组特性[J].中国动物检疫,2020,37(5):37-42. WANG J J,YU X H,LUO Y Y,et al.Genomic characteristics of five strains of genotype Ⅶ Newcastle disease viruses isolated in China from 2014 to 2018[J].China Animal Health Inspection,2020,37(5):37-42.(in Chinese)
[6] DIMITROV K M,ABOLNIK C,AFONSO C L,et al.Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus[J].Infection,Genetics and Evolution,2019,74(10):103917.
[7] 熊晓妍,覃振斌,莫红芳,等.VA5免疫增强剂对鸽新城疫病毒灭活疫苗的增效作用研究[J].中国畜牧兽医,2020,47(12):4032-4040. XIONG X Y,QIN Z B,MO H F,et al.Study on synergistic effect of VA5 immunopotentiator on pigeon NDV inactivated vaccine[J].China Animal Husbandry & Veterinary Medicine,2020,47(12):4032-4040.(in Chinese)
[8] 武发菊,刘学荣,尚勇良,等.新城疫疫苗的研究进展[J].中国畜牧兽医,2011,38(10):145-148. WU F J,LIU X R,SHANG Y L,et al.Identification and complete genomic analysis of a Newcastle disease virus from a laying hen[J].China Animal Husbandry & Veterinary Medicine,2011,38(10):145-148.(in Chinese)
[9] 凌媛,金苏,李敏.病毒样颗粒疫苗的研究进展及研发考虑要点[J].中华微生物学和免疫学杂志,2020,40(5):393-398. LING Y,JIN S,LI M.Structure and organization of paramyxovirus particles[J].Chinese Journal of Microbiology and Immunology,2020,40(5):393-398.(in Chinese)
[10] COX R M,PLEMPER R K.Structure and organization of paramyxovirus particles[J].Current Opinion in Virology,2017,24:105-114.
[11] SONG H,ZHONG L P,HE J,et al.Application of Newcastle disease virus in the treatment of colorectal cancer[J].World Journal of Clinical Cases,2019,7(16):2143-2154.
[12] ARIYAMA N,TAPIA R,GODOY C,et al.Avian orthoavulavirus 1 (Newcastle disease virus) antibodies in five penguin species,Antarctic peninsula and Southern Patagonia[J].Transboundary and Emerging Diseases,2021,68(6):3096-3102.
[13] MOHARAM I,ASALA O,REICHE S,et al.Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.Ⅶ from Egypt[J].Virology Journal,2021,18(1):86.
[14] 李佳佳,宋建领.一株蛋鸡新城疫病毒的分离鉴定及全基因组序列分析[J].中国畜牧兽医,2020,47(1):221-228. LI J J,SONG J L.Identification and complete genomic analysis of a Newcastle disease virus from a laying hen[J].China Animal Husbandry & Veterinary Medicine,2020,47(1):221-228.(in Chinese)
[15] KIANI M H,BOZORGMEHRIFARD M H,HOSSEINI H,et al.Hemagglutinin-neuraminidase sequence and phylogenetic analysis of two Newcastle disease virus isolated from chickens in Iran[J].Archives of Razi Institute,2021,76(1):31-39.
[16] LIU Y,LIU Y,HUANG Y,et al.The effect of the HRB linker of Newcastle disease virus fusion protein on the fusogenic activity[J].Journal of Microbiology (Seoul,Korea),2021,59(5):513-521.
[17] DUAN Z,YUAN C,HAN Y,et al.TMT-based quantitative proteomics analysis reveals the attenuated replication mechanism of Newcastle disease virus caused by nuclear localization signal mutation in viral matrix protein[J].Virulence,2020,11(1):607-635.
[18] 贾妙妙,王国康,李丽,等.基于新城疫病毒NP蛋白的间接ELISA抗体检测方法的建立[J].中国兽医学报,2021,41(3):475-479. JIA M M,WANG G K,LI L,et al.Development of an indirect ELISA for NDV antibody detection based on NP protein[J].Chinese Journal of Veterinary Science,2021,41(3):475-479.(in Chinese)
[19] KARSUNKE J,HEIDEN S,MURR M,et al.W protein expression by Newcastle disease virus[J].Virus Research,2019,263:207-216.
[20] SUN Y,ZHENG H,YU S,et al.Newcastle disease virus V protein degrades mitochondrial antiviral signaling protein to inhibit host type Ⅰ interferon roduction via E3 ubiquitin ligase RNF5[J].Journal of Virology,2019,93(18):e00322-19.
[21] YANG Y,XUE J,TENG Q,et al.Mechanisms and consequences of Newcastle disease virus W protein subcellular localization in the nucleus or mitochondria[J].Journal of Virology,2021,95(7):e02087-20.
[22] CHEN X,JIA Y,REN S,et al.Identification of Newcastle disease virus P-gene editing using next-generation sequencing[J].The Journal of Veterinary Medical Science,2020,82(8):1231-1235.
[23] 辛梅.鸡毒支原体TM-1蛋白嵌合型新城疫病毒样颗粒的构建及免疫效果评价[D].长春:吉林大学,2021. XIN M.Construction and immune effect evaluation of chimeric Newcastle disease virus-like particles containing Mycoplasma galisepticum TM-1 protein[D].Changchun:Jilin University,2021.(in Chinese)
[24] 王席,李国攀,陈清清,等.猪圆环病毒2型病毒样颗粒的纯化及鉴定[J].中国畜牧兽医,2019,46(6):1792-1800. WANG X,LI G P,CHEN Q Q,et al.Identification and complete genomic analysis of a Newcastle disease virus from a laying hen[J].China Animal Husbandry & Veterinary Medicine,2019,46(6):1792-1800.(in Chinese)
[25] 宋亚鹏,刘运超,姬鹏超,等.新城疫疫苗的研究进展[J].中国兽医学报,2017,37(2):376-380. SONG Y P,LIU Y C,JI P C,et al.Research progress of Newcastle disease vaccine[J].Chinese Journal of Veterinary Science,2017,37(2):376-380.(in Chinese)
[26] 钱晶.新城疫病毒样颗粒的构建及免疫原性和免疫机制研究[D].长春:吉林大学,2017. QIAN J.The construction of Newcastle disease virus-like particles and the study of its immunogenicity and immune mechanism[D].Changchun:Jilin University,2017.(in Chinese)
[27] PANTUA H D,MC GINNES L W,PEEPLES M E,et al.Requirements for the assembly and release of Newcastle disease virus-like particles[J].Journal of Virology,2006,80(22):11062-11073.
[28] MOHSEN M O,GOMES A C,CABRAL-MIRANDA G,et al.Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination[J].Journal of Controlled Release,2017,251:92-100.
[29] OLIVE C.Pattern recognition receptors:Sentinels in innate immunity and targets of new vaccine adjuvants[J].Expert Review of Vaccines,2012,11(2):237-256.
[30] ZEPEDA-CERVANTES J,RAMREZ-JARQUN J O,VACA L.Interaction between virus-like particles (VLPs) and pattern recognition receptors (PRRs) from dendritic cells (DCs):Toward better engineering of VLPs[J].Frontiers in Immunology,2020,11:1100.
[31] YAN M,PENG J,JABBAR I A,et al.Activation of dendritic cells by human papilloma virus-like particles through TLR4 and NF-kappaB-mediated signalling,moderated by TGF-beta[J].Immunology and Cell Biology,2005,83(1):83-91.
[32] QIAN J,XU X,DING J,et al.Newcastle disease virus-like particles induce DC maturation through TLR4/NF-κB pathway and facilitate DC migration by CCR7-CCL19/CCL21 axis[J].Veterinary Microbiology,2017,203:158-166.
[33] 丁佳欣,钱晶,徐小洪,等.新城疫病毒样颗粒对树突状细胞成熟的影响[J].中国兽医学报,2017,37(8):1485-1489. DING J X,QIAN J,XU X H,et al.Effect of Newcastle disease virus-like particles on dendritic cell maturation[J].Chinese Journal of Veterinary Science,2017,37(8):1485-1489.(in Chinese)
[34] QIAN J,DING J,YIN R,et al.Newcastle disease virus-like particles induce dendritic cell maturation and enhance viral-specific immune response[J].Virus Genes,2017,53(4):555-564.
[35] NINYIO N N,HO K L,OMAR A R,et al.Virus-like particle vaccines:A prospective panacea against an avian influenza panzootic[J].Vaccines (Basel),2020,8(4):694.
[36] 丁佳欣.基因Ⅱ型、Ⅶ型二价新城疫病毒样颗粒的构建及免疫效果评价[D].长春:吉林大学,2019. DING J X.Construction of genotype Ⅱ and Ⅶ bivalent Newcastle disease virus-like particles and evaluation of immune effect[D].Changchun:Jilin University,2019.(in Chinese)
[37] CULLEN M G,SCHMIDT M R,KENWARD S A,et al.Murine immune responses to virus-like particle associated pre- and post-fusion forms of the Respiratory syncytial virus F protein[J].Journal of Virology,2015,89(13):6835-6847.
[38] DIAMOS A G,LARIOS D,BROWN L,et al.Vaccine synergy with virus-like particle and immune complex platforms for delivery of human papillomavirus L2 antigen[J].Vaccine,2019,37(1):137-144.
[39] LI Z J,LI Y,CHANG S,et al.Antigenic variation between Newcastle disease viruses of goose and chicken origin[J].Archives of Virology,2010,155(4):499-505.
[40] 刘秀梵,胡顺林.新城疫病毒的进化及其新型疫苗的研制[J].中国兽药杂志,2010,44(1):12-18. LIU X F,HU S L.The evolution of Newcastle disease virus and the development of a new vaccine[J].Chinese Journal of Veterinary Medicine,2010,44(1):12-18.(in Chinese)
[41] XU X,QIAN J,QIN L,et al.Chimeric Newcastle disease virus-like particles containing DC-binding peptide-fused haemagglutinin protect chickens from virulent Newcastle disease virus and H9N2 Avian influenza virus challenge[J].Virologica Sinica,2020,35(4):455-467.
[42] 袁乾亮,钱晶,薛聪,等.基因Ⅶ型新城疫病毒样颗粒的制备与鉴定[J].中国兽医学报,2016,36(1):18-23. YUAN Q L,QIAN J,XUE C,et al.Preparation and identification of the genotype Ⅶ Newcastle disease virus-like particles[J].Chinese Journal of Veterinary Science,2016,36(1):18-23.(in Chinese)
[43] XU X,DING Z,LI J,et al.Newcastle disease virus-like particles containing the Brucella BCSP31 protein induce dendritic cell activation and protect mice against virulent Brucella challenge[J].Veterinary Microbiology,2019,229:39-47.
[44] 袁乾亮,丁佳欣,高一丹,等.基因Ⅶ型新城疫病毒样颗粒作为疫苗候选株的免疫效果[J].中国兽医学报,2017,37(2):201-205. YUAN Q L,DING J X,GAO Y D,et al.Immune effect of genotype Ⅶ ND VLPs as a vaccine candidate[J].Chinese Journal of Veterinary Science,2017,37(2):201-205.(in Chinese)
[45] XU X,DING Z,YUAN Q,et al.Genotype Ⅶ Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding[J].Vaccine,2019,37(3):444-451.
[46] PARK J K,LEE D H,YUK S S,et al.Virus-like particle vaccine confers protection against a lethal Newcastle disease virus challenge in chickens and allows a strategy of differentiating infected from vaccinated animals[J].Clinical and Vaccine Immunology,2014,21(3):360-365.
[47] KIM S H,SAMAL S K.Innovation in Newcastle disease virus vectored avian influenza vaccines[J].Viruses,2019,11(3):300.
[48] 秦岭松.新城疫-H9N2亚型禽流感嵌合病毒样颗粒的构建及免疫原性研究[D].长春:吉林大学,2018. QIN L S.Construction and immune effect study of Newcastle disease-H9N2 Avian influenza chimeric virus-like particles[D].Changchun:Jilin University,2018.(in Chinese)
[49] SHEN H,XUE C,LV L,et al.Assembly and immunological properties of a bivalent virus-like particle (VLP) for avian influenza and Newcastle disease[J].Virus Research,2013,178(2):430-436.
[50] 陈恒,蓝佳明,杨扬,等.高致病性人禽流感H5N1病毒HA与M1蛋白共表达制备新型病毒样颗粒[J].中华微生物学和免疫学杂志,2015,35(4):286-291. CHEN H,LAN J M,YANG Y,et al.Co-expression of HA and M1 proteins of highly pathogenic human Avian influenza H5N1 virus to prepare novel virus-like particles[J].Chinese Journal of Microbiology and Immunology,2015,35(4):286-291.(in Chinese)
[51] SHI T,MCALLISTER D A,O’BRIEN K L,et al.Global,regional,and national disease burden estimates of acute lower respiratory infections due to Respiratory syncytial virus in young children in 2015:A systematic review and modelling study[J].Lancet (London,England),2017,390(10098):946-958.
[52] 柯胜忠,张多.支气管肺发育不良患儿发生急性病毒性下呼吸道感染的预测因素分析[J].中国免疫学杂志,2018,34(6):911-914. KE S Z,ZHANG D.Predictors factor analysis of acute viral lower respiratory tract infection in children with bronchopulmonary dysplasia[J].Chinese Journal of Immunology,2015,31(2):257-260.(in Chinese)
[53] 王加芬,王凤秀,郑媛媛,等.呼吸道病毒特异性IgM检测对儿童呼吸道感染的指导意义[J].中国免疫学杂志,2015,31(2):257-260. WANG J F,WANG F X,ZHENG Y Y,et al.Guiding significance of respiratory virus specific IgM in children with respiratory tract infection[J].Chinese Journal of Immunology,2015,31(2):257-260.(in Chinese)
[54] TALEB S A,AL THANI A A,AL ANSARI K,et al.Human respiratory syncytial virus:Pathogenesis,immune responses,and current vaccine approaches[J].European Journal of Clinical Microbiology & Infectious Diseases,2018,37(10):1817-1827.
[55] PATEL N,MASSARE M J,TIAN J H,et al.Respiratory syncytial virus prefusogenic fusion (F) protein nanoparticle vaccine:Structure,antigenic profile,immunogenicity,and protection[J].Vaccine,2019,37(41):6112-6124.
[56] BLANCO J C G,PLETNEVA L M,MCGINNES-CULLEN L,et al.Efficacy of a Respiratory syncytial virus vaccine candidate in a maternal immunization model[J].Nature Communications,2018,9(1):1904.
[57] CULLEN L M,BOUKHVALOVA M S,BLANCO J C G,et al.Comparisons of antibody populations in different pre-fusion F VLP-immunized cotton rat dams and their offspring[J].Vaccines (Basel),2020,8(1):133.
[58] MCGINNES L W,GRAVEL K A,FINBERG R W,et al.Assembly and immunologicalp properties of Newcastle disease virus-like particles containing the Respiratory syncytial virus F and G proteins[J].Journal of Virology,2011,85(1):366-377.

Research Progress on Newcastle Disease Virus-like Particles

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	HAN Bing, TANG Siqi, ZHU Dawei, LI Hailing, FENG Yali, SU Chaofan, XU Yina, LENG Haoyu, WANG Yongtao, ZHANG Yuemei, TAI Xiaochun, ZHANG Ying. Research Progress of Novel Vaccine Adjuvants [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(6): 2460-2467.
[2]	YU Xingang, YUAN Kaijian, MU Xuanru, WANG Hongcai, QI Nanshan, ZHANG Haoji. Research Progress on the Formation of Cyst Wall and Cyst Wall Proteins of Giardia [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(5): 2061-2068.
[3]	CHEN Tianbao, WANG Yani, LIU Baoling, WANG Gang, WANG Xiaohu, LIU Xuhui, CAI Rujian, HE Dongsheng. Research Progress on the Anti-Porcine Reproductive and Respiratory Syndrome Virus Effect and Mechanism of Traditional Chinese Medicine [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(5): 2114-2129.
[4]	CHEN Jimin, LI Huihuang, LAI Lianjie, YANG Yinhua, YANG Yue, LIN Ruiyi. Advance on Detection Methods and Vaccines of Duck Tembusu Virus [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(4): 1329-1339.
[5]	LIU Xinyue, LI Lifang, WANG Zhenbao, ZHANG Wenliang, ZHANG Xin, ZHAO Hongtao, LI Pengyu, ZHENG Haotian, XIAO Jin, QI Peng. Adjuvants Screening and Immune Protection of Porcine Circovirus Type 2 Synthetic Peptide Vaccine [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(3): 1068-1080.
[6]	LIU Xin, PAN Jimai, HU Andong, ZENG Chengrong, YANG Ying, CHENG Zhentao, CHEN Jiangfeng, JIANG Haibo, WEN Ming. Effect of Astragalus Polysaccharides on Inactivated Aeromonas hydrophila Vaccine for Hybrid Sturgeon [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(3): 1177-1184.
[7]	LI Qi, TIAN Ye, HUANG Tao, LIU Cunxia. Research Progress of Nano-vaccine in the Prevention and Control of Avian Influenza [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(2): 684-692.
[8]	XU Jinge, LI Ting, CHEN Rujia, YU Bo, ZHANG Yanan, YANG Li, ZHAO Bin, PU Ling. Preparation and Immune Efficacy of Riemerella anatipestifer Bivalent Inactivated Vaccine [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(1): 290-299.
[9]	LIU Hongying, WANG Jingyu, CUI Zhenzhen, MA Qingxia, WANG Tingting, LI Jianming, SHI Kun, GONG Qinglong, DU Rui, LENG Xue. Research Progress on Immune Adjuvant Effect and Related Mechanism of Active Ingredients of Traditional Chinese Medicine on Animal Vaccines [J]. China Animal Husbandry and Veterinary Medicine, 2023, 50(1): 390-397.
[10]	ZHAO Fengmiao, GUO Ting, ZHOU Yaping, ZHAO Hongmei, WANG Yuchen, TIAN Guangyuan, SUN Yajie, BIAN Yuchen, YU Jialiang, HAO Yongqing. Pathogenicity Analysis of Bovine Viral Diarrhea Virus and Immune Effect Evaluation of E2 Protein in New Zealand White Rabbits [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(9): 3549-3558.
[11]	JIA Xinyue, MA Jing, ZHANG Yanyan, MA Xun, WANG Zhengrong, BO Xinwen. Research Progress on Oral Vaccine of Animal Parasites [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(9): 3569-3580.
[12]	XU Yaling, ZHANG Jihui, NIU Xi, LI Sheng, HUANG Shihui, RAN Xueqin, WANG Jiafu. Construction of Synthetic Peptide Vaccine of African Classical Swine Fever Virus P72 Protein and Evaluation of Its Immune Efficacy [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(8): 3083-3090.
[13]	WANG Yuchen, TIAN Guangyuan, ZHOU Yaping, GUO Ting, ZHAO Hongmei, SUN Yajie, ZHAO Fengmiao, BIAN Yuchen, YU Jialiang, HAO Yongqing. Prokaryotic Expression of BPIV3 NP Protein and Its Immunoenhancing Effect on the BPIV3 Inactivated Vaccine [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(8): 3122-3130.
[14]	MA Guangqiang, LIU Lijuan, CHEN Guoquan, WU Liangtao, YANG Jun, LIU Junze, LI Xiaomeng, PAN Chengwen, ZHOU Bijun. Preparation of Propolis Inactivated Vaccine of Riemerella anatipestifer Epidemic Strain in Guizhou [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(8): 3163-3170.
[15]	TIAN Yujie, LI Ting, DAI Guotao, PU Ling, ZHANG Yanan, YUAN Chao, YANG Maosheng, CHEN Qiang, LI Meijuan, XU Jinge. Preparation and Immunological Study of Inactived Vaccine of Type A: L1 Pasteurella multocida from Ducks [J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(7): 2716-2724.